Por: RTTNews Health August 22, 2023
The U.S. Food and Drug Administration announced the approval of Pfizer Inc.'s Abrysvo (Respiratory Syncytial Virus Vaccine) for use in pregnant individuals to prevent respiratory syncytial virus or RSV in infants.It is the first vaccine approval for use in pregnant individuals to prevent lower respiratory tract disease or LRTD and severe LRTD caused by RSV in infants from birth through 6 months of age.RSV is a highly contagious virus that... + full article
CBS News USA Health August 22, 2023
Expectant parents could soon have another new option this fall to protect their newborns from RSV, or respiratory syncytial virus, the most common cause of hospitalization in American infants, after the Food and Drug Administration announced Monday that it has widened its... + más
Pfizer’s RSV Vaccine for Pregnant Women Wins FDA Panel Support | Time
Pfizer says study shows vaccinating pregnant women protects newborns from RSV | ABC7
Portland Press Herald USA Health August 22, 2023
WASHINGTON — U.S. regulators on Monday approved the first RSV vaccine for pregnant women so their babies will be born with protection against the scary respiratory infection. RSV is notorious for filling hospitals with wheezing babies every fall and winter. The Food and Drug... + más
Strong RSV vaccine data lifts hopes after years of futility | 10 WBNS
ABC7 USA World August 22, 2023
called nirsevimab -- a monoclonal antibody shot that is recommended for all infants less than 8 months old.We're hopeful that these two [immunizations] will work together so that we can provide the most protection to the most individuals possible, Dr. Elizabeth... + más
1st RSV vaccine could be approved this summer | ABC7
First-ever RSV vaccine could be approved, roll out by August | New York Post
CBS News USA Politics July 17, 2023
The Food and Drug Administration announced Monday it had approved a new kind of immunization to protect babies from . The drug, nirsevimab, is one of two new options doctors hope could soon prevent the leading cause of hospitalization facing American infants.Outside advisers to... + más
Time USA Health June 01, 2023
After decades of having no vaccines to fight respiratory syncytial respiratory (RSV), the U.S. now has two—both aimed at protecting older adults. On May 31, the U.S. Food and Drug Administration (FDA) approved the second RSV vaccine in the world. The first, from the... + más
CBS News USA Health May 19, 2023
The first vaccine to protect babies from the is a step closer to approval, after a panel of the Food and Drug Administration's outside vaccine advisers voted Thursday to back the safety and effectiveness of a new shot developed by Pfizer, branded as Abrysvo. If ultimately... + más
ABC7 USA World February 21, 2023
against , could be approved by August.Pfizer, the maker of the vaccine, that the U.S. Food and Drug Administration has accepted its application for review and will make a decision on whether or not to approve the vaccine by August 2023.If approved, RSVpreF would help protect... + más
Strong RSV vaccine data lifts hopes after years of futility | WPLG Local 10
About iurex | Privacy Policy | Disclaimer |